$1.43 Billion is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 134 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENPH | ENPHASE ENERGY INCcall | $42,235,000 | +13.2% | 230,000 | 0.0% | 2.86% | -0.1% | |
| MSFT | MICROSOFT CORP | $18,295,000 | +14.9% | 67,536 | 0.0% | 1.24% | +1.3% | |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $8,245,000 | -14.2% | 832,878 | 0.0% | 0.56% | -24.3% | |
| BLSA | BCLS ACQUISITION CORP | $7,244,000 | -0.4% | 687,900 | 0.0% | 0.49% | -12.2% | |
| BGNE | BEIGENE LTDsponsored adr | $7,173,000 | -1.4% | 20,900 | 0.0% | 0.48% | -13.1% | |
| RACB | RESEARCH ALLIANCE CORP II | $6,000,000 | -2.4% | 600,000 | 0.0% | 0.41% | -14.0% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $5,999,000 | -39.5% | 1,366,564 | 0.0% | 0.41% | -46.6% | |
| STRO | SUTRO BIOPHARMA INC | $5,481,000 | -18.3% | 294,825 | 0.0% | 0.37% | -28.0% | |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $5,360,000 | +3.1% | 500,000 | 0.0% | 0.36% | -9.0% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $5,240,000 | -21.8% | 801,256 | 0.0% | 0.35% | -31.1% | |
| CYCC | CYCLACEL PHARMACEUTICALS INC | $3,009,000 | -16.7% | 508,322 | 0.0% | 0.20% | -26.4% | |
| ARGX | ARGENX SEsponsored adr | $2,785,000 | +9.3% | 9,249 | 0.0% | 0.19% | -3.6% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $2,170,000 | +1.2% | 219,440 | 0.0% | 0.15% | -10.4% | |
| JYAC | JIYA ACQUISITION CORP | $1,978,000 | +1.0% | 199,028 | 0.0% | 0.13% | -10.7% | |
| HCAQ | HEALTHCOR CATALIO ACQU CORP | $1,970,000 | -1.5% | 200,000 | 0.0% | 0.13% | -13.1% | |
| WIX | WIX COM LTD | $1,655,000 | +4.0% | 5,700 | 0.0% | 0.11% | -8.2% | |
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $1,237,000 | -1.9% | 126,687 | 0.0% | 0.08% | -13.4% | |
| OMEG | OMEGA ALPHA SPACcl a | $995,000 | +0.5% | 100,000 | 0.0% | 0.07% | -11.8% | |
| ETAC | E MERGE TECHNOLOGY ACQUISITI | $976,000 | +0.1% | 100,000 | 0.0% | 0.07% | -12.0% | |
| NICE SYS INCnote 1.250% 1/1 | $731,000 | +9.8% | 250,000 | 0.0% | 0.05% | -3.9% | ||
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $344,000 | +16.6% | 100,000 | 0.0% | 0.02% | 0.0% | |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $237,000 | -2.1% | 23,900 | 0.0% | 0.02% | -15.8% | |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $49,000 | -62.6% | 129,500 | 0.0% | 0.00% | -70.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Sphera Global Healthcare GP Ltd #1
- Sphera Global Healthcare Management LP #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
| SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.